Revolution Medicines, Inc. (RVMD)
153.73
+3.40
(+2.26%)
USD |
NASDAQ |
May 21, 16:00
154.28
+0.55
(+0.36%)
After-Hours: 19:59
Revolution Medicines Research and Development Expense (TTM) : 1.117B for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tango Therapeutics, Inc. | 127.14M |
| Insmed, Inc. | 828.00M |
| Erasca, Inc. | 94.15M |
| Travere Therapeutics, Inc. | 216.22M |
| Spyre Therapeutics, Inc. | 190.44M |